Posts by Christopher

As Addimmune, a division of American Gene Technologies dedicated to developing a gene therapy to cure HIV, we understand the challenges and opportunities that come with fundraising in the biotech industry. This article explores the experiences of four different biotech companies and the strategies they used to secure funding. The report highlights that while overall…

The video discusses AGT 103-T, which is being developed by Addimmune, the HIV division of American Gene Technologies. AGT 103-T is designed to target HIV-1, the most common strain of HIV, by using CD4+T cells. CD4+T cells are a type of white blood cell that helps the immune system fight off infection. AGT 103-T works…

At Addimmune, the HIV division of American Gene Technologies, we are keenly interested in any advancements in the field of gene therapy, particularly those that can inform the development of our own HIV gene therapy cure. This article explores some of the key events and trends that shaped the biopharmaceutical industry in 2023. A significant…

Addimmune, the HIV division of American Gene Technologies, believes that the time for transformative HIV treatment change is now. While antiretroviral therapies (ART) are effective, challenges remain with non-adherence and treatment failure leading to ongoing transmission risk for many patients. Why Gene and Cell Therapy? This modality has proven successful against other diseases. In HIV,…

Access to the desired content is restricted by a paywall. To proceed to the publisher’s website, kindly follow the provided link. https://www.sun-sentinel.com/2023/12/02/miami-beach-a-hotspot-for-nightlife-and-a-hotspot-for-new-hiv-infections/

Access to the desired content is restricted by a paywall. To proceed to the publisher’s website, kindly follow the provided link.  https://www.sun-sentinel.com/2023/12/01/south-floridas-hiv-dilemma-how-to-prevent-babies-from-being-born-with-the-disease/

Access to the desired content is restricted by a paywall. To proceed to the publisher’s website, kindly follow the provided link. https://www.bizjournals.com/sanfrancisco/news/2023/12/01/hiv-world-aids-day-cure-marcus-conant-ucsf.html

At Addimmune, we are excited to see this article highlighting the progress being made in the fight against HIV. As the article mentions, Addimmune, the HIV division of American Gene Technologies, is at the forefront of developing a gene and cell therapy to cure HIV. Our therapy focuses on modifying HIV-infected CD4 T cells to…

At Addimmune, a division of American Gene Technologies dedicated to developing a cure for HIV using gene therapy, we are inspired by the stories of Jeff Galvin and Terry Pirovolakis, highlighted in this article. The article explores the career paths of these two CEOs who successfully transitioned from the IT industry to lead gene therapy…